跳至主要内容
临床试验/NCT02744404
NCT02744404已完成不适用

Evaluation of the Clinical Impact of Point-of-Care HIV Early Infant Diagnostic Technologies

Clinton Health Access Initiative Inc.7 个研究点 分布在 1 个国家目标入组 1,752 人开始时间: 2015年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,752
试验地点
7
主要终点
ART initiation retention

研究概览

简要总结

In Malawi, early infant HIV diagnosis (EID, i.e. HIV screening of infants under 18 months of age) is conducted using molecular diagnostics at central laboratories. However, test volumes are growing and many parts of the country do not have close or easy access to laboratories. Test samples are transported over large distances and this can introduce testing delays, especially for patients in rural and remote areas of the country. There are growing numbers of high quality Point-Of-Care (POC) diagnostic technologies available and there is increasing interest in using these technologies to alleviate critical testing needs. This protocol describes an observational study looking at the patient impact of implementing POC EID technologies within the routine standard of care at seven facilities.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
— 至 12 Months(Child)
性别
All
接受健康志愿者

入选标准

  • Younger than 12 months of age
  • Clinical or other indication for an EID test (screen or confirmation), such as birth to an HIV-positive mother

排除标准

  • Older than 12 months of age
  • Serious medical conditions which would make testing dangerous for the infant, or disrupt the accuracy of normal laboratory analysis and its interpretation
  • Already initiated ART

结局指标

主要结局

ART initiation retention

时间窗: 6-9 months

Proportion of HIV-positive infants initiated on anti-retroviral therapy

次要结局

  • Test turnaround time(6-9 months)
  • Tests received(6-9 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (7)

Loading locations...

相似试验